Haggai Bar‐Yoseph - Concepedia

Author

Haggai Bar‐Yoseph

Rambam Health Care Campus ORCID

Also Known As

H Bar-Yoseph, H. Bar-Yoseph, H. Bar-yoseph, H. Bar‐Yoseph, Haggai Bar-Yoseph, Haggai Bar-yoseph, Haggai Bar‐Yoseph

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Rambam Health Care Campus Technion – Israel Institute of Technology Tel Aviv University Sheba Medical Center Tel Aviv Sourasky Medical Center

About

Haggai Bar‐Yoseph is an author at Rambam Health Care Campus specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	145
2	Health Sciences	3	3	46
3	Public Health	1	1	20
4	Allergy	1	1	10
5	Anatomy	1	1	17

Haggai Bar‐Yoseph

Publications

597

Citations

H-Index

Page 1

	Year	Citations
Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn’s Disease Yana Davidov, Bella Ungar, Haggai Bar‐Yoseph, Journal of Crohn s and Colitis	2016	134
Early drug and anti‐infliximab antibody levels for prediction of primary nonresponse to infliximab therapy Haggai Bar‐Yoseph, Nina Levhar, L Selinger, Alimentary Pharmacology & Therapeutics	2017	78
Oral Capsulized Fecal Microbiota Transplantation for Eradication of Carbapenemase-producing <i>Enterobacteriaceae</i> Colonization With a Metagenomic Perspective Haggai Bar‐Yoseph, Shaqed Carasso, Shlomit Shklar, Clinical Infectious Diseases	2020	63
Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis Yu Fujita, Ali Khateb, Yan Li, Cell Reports	2018	58
Infliximab–Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies Haggai Bar‐Yoseph, Sigal Pressman, Alexandra Blatt, Gastroenterology InflammationAnti-inflammatoryAutoimmune DiseaseImmunologyAntibody Engineering	2019	35
The gut microbiota promotes pain in fibromyalgia Weihua Cai, May Haddad, R. Haddad, Neuron	2025	28
Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines Haggai Bar‐Yoseph, Matti Waterman, Ronit Almog, Clinical Gastroenterology and Hepatology InflammationPrior FailureAnti-inflammatoryAutoimmune DiseaseMedicine	2016	27
GLP-1 Analog Use is Associated With Improved Disease Course in Inflammatory Bowel Disease: A Report from the Epi-IIRN Yuri Gorelik, Itai Ghersin, Rona Lujan, Journal of Crohn s and Colitis	2024	24
Severe cytomegalovirus enterocolitis developing following daratumumab exposure in three patients with multiple myeloma Noa Lavi, Doaa Okasha, Edmond Sabo, European Journal Of Haematology	2018	23
Risk factors for mortality among carbapenem-resistant enterobacteriaceae carriers with focus on immunosuppression Haggai Bar‐Yoseph, Nadav Cohen, Alexander Korytny, Journal of Infection Antimicrobial SusceptibilityCarbapenem-resistant Enterobacteriaceae CarriersHealth SciencesMicrobiologyInfection Control	2018	22

Page 1